- Investing Ideas
- Global Pharmaceuticals & Biotech Top Growth Stocks
Global Pharmaceuticals & Biotech Top Growth Stocks
Results
68
68 companies
Madrigal Pharmaceuticals
Market Cap: US$11.8b
A biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
MDGL
US$518.66
7D
-0.3%
1Y
69.3%
Travere Therapeutics
Market Cap: US$4.1b
A biopharmaceutical company, identifies, develops, and delivers therapies to people living with rare kidney and metabolic diseases in the United States.
TVTX
US$44.91
7D
10.0%
1Y
109.8%
Zevra Therapeutics
Market Cap: US$595.3m
A commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States.
ZVRA
US$10.05
7D
2.4%
1Y
25.6%
Camurus
Market Cap: SEK 32.7b
A biopharmaceutical company, develops and commercializes medicines for severe and chronic diseases in Europe, Africa, the Middle East, North America, and Asia.
CAMX
SEK 547.50
7D
1.9%
1Y
-17.0%
Syndax Pharmaceuticals
Market Cap: US$1.7b
A commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.
SNDX
US$19.96
7D
-5.0%
1Y
47.1%
Bora Pharmaceuticals
Market Cap: NT$51.6b
Engages in contract development, manufacture, and sale of pharmaceuticals in Europe, the United States, Taiwan, and internationally.
6472
NT$407.50
7D
-0.1%
1Y
-30.7%
HansBiomed
Market Cap: ₩425.7b
Engages in the research and development, production, and sale of medical materials for the procedure and the raw materials for medical supplies.
A042520
₩29,850.00
7D
-10.0%
1Y
306.1%
Bonesupport Holding
Market Cap: SEK 14.9b
An orthobiologics company, develops and sells injectable bio-ceramic bone graft substitutes in Europe, North America, and internationally.
BONEX
SEK 225.80
7D
-0.3%
1Y
-28.5%
Insmed
Market Cap: US$28.8b
Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.
INSM
US$140.01
7D
3.0%
1Y
92.9%
AnaptysBio
Market Cap: US$1.9b
A clinical-stage biotechnology company, focuses in delivering immunology therapeutics for autoimmune and inflammatory diseases in the United States.
ANAB
US$69.78
7D
4.8%
1Y
236.6%
Rhythm Pharmaceuticals
Market Cap: US$5.6b
A commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases in the United States and internationally.
RYTM
US$85.58
7D
0.4%
1Y
32.9%
Ardelyx
Market Cap: US$1.7b
Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally.
ARDX
US$7.30
7D
21.9%
1Y
95.4%
Keymed Biosciences
Market Cap: HK$21.8b
A biotechnology company, engages in the discovery and development of biological therapies in the autoimmune and oncology therapeutic areas in Mainland China and internationally.
2162
HK$73.95
7D
-2.2%
1Y
54.1%
WuXi XDC Cayman
Market Cap: HK$74.5b
An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.
2268
HK$59.15
7D
2.0%
1Y
52.6%
Guard Therapeutics International
Market Cap: SEK 20.2m
A clinical-stage biotechnology company, identifies and develops medicines to treat kidney diseases in Sweden.
GUARD
SEK 1.00
7D
-2.7%
1Y
-92.8%
Imexpharm
Market Cap: ₫7.7t
Operates as a pharmaceutical company in Vietnam.
IMP
₫49,900.00
7D
3.2%
1Y
14.7%
Capricor Therapeutics
Market Cap: US$1.8b
A clinical-stage biotechnology company, engages in the development of transformative cell and exosome-based therapeutics for treating duchenne muscular dystrophy (DMD) and other diseases with unmet medical needs in the United States.
CAPR
US$33.50
7D
-4.6%
1Y
225.2%
Aldeyra Therapeutics
Market Cap: US$95.7m
A biotechnology company, discovers and develops therapies designed to treat immune-mediated diseases.
ALDX
US$1.62
7D
2.5%
1Y
-40.0%
Pelthos Therapeutics
Market Cap: US$83.9m
A bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens.
PTHS
US$24.82
7D
0.2%
1Y
108.6%
ARS Pharmaceuticals
Market Cap: US$850.0m
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions in the United States and internationally.
SPRY
US$8.83
7D
11.1%
1Y
-38.1%
Pharma Mar
Market Cap: €1.8b
A biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, rest of the European Union, the United States, and internationally.
PHM
€101.30
7D
4.6%
1Y
32.2%
Clinuvel Pharmaceuticals
Market Cap: AU$466.5m
A biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally.
CUV
AU$9.55
7D
4.6%
1Y
-15.5%
CG Oncology
Market Cap: US$5.8b
A late-stage clinical biopharmaceutical company, develops and commercializes cretostimogene grenadenorepvec for patients with bladder cancer in the United States.
CGON
US$67.70
7D
1.3%
1Y
140.2%
Arcutis Biotherapeutics
Market Cap: US$2.9b
A biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases.
ARQT
US$23.49
7D
0.3%
1Y
52.4%
Oxford Biomedica
Market Cap: UK£716.9m
A contract development and manufacturing organization, focuses on delivering therapies to patients worldwide.
OXB
UK£5.93
7D
-1.3%
1Y
97.7%
Senores Pharmaceuticals
Market Cap: ₹41.2b
Develops, manufactures, sells, and trades in pharmaceutical and allied products in India, the United States, the United Kingdom, Canada, and internationally.
SENORES
₹894.25
7D
-4.8%
1Y
76.9%
IDL Diagnostics
Market Cap: SEK 78.3m
A vitro diagnostics company, manufactures and sells IVD tests for oncological and bacterial diseases in Sweden.
IDLDX
SEK 0.34
7D
-6.8%
1Y
-42.2%
Belite Bio
Market Cap: US$6.1b
A clinical stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics with unmet medical needs in the United States.
BLTE
US$154.51
7D
-5.2%
1Y
147.2%
Kuros Biosciences
Market Cap: CHF 783.5m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 20.00
7D
-9.8%
1Y
-26.7%
Genovis AB (publ.)
Market Cap: SEK 1.3b
Develops and sells tools for the development of new treatment methods and diagnostics in North America, Europe, and Asia.
GENO
SEK 19.90
7D
-0.7%
1Y
-16.4%
Devyser Diagnostics
Market Cap: SEK 1.5b
Provides diagnostic kits and advanced analysis services for clinical genetics and post-transplantation laboratories in Sweden, rest of Europe, the Middle East, and Africa.
DVYSR
SEK 89.10
7D
-7.1%
1Y
-15.6%
Verrica Pharmaceuticals
Market Cap: US$107.7m
A dermatology therapeutics company, engages in the development and commercialization of medications for the treatment of dermatologic diseases in the United States.
VRCA
US$6.36
7D
-6.8%
1Y
42.7%
SIGA Technologies
Market Cap: US$329.6m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$4.63
7D
1.5%
1Y
-14.3%
Neurocrine Biosciences
Market Cap: US$13.3b
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally.
NBIX
US$134.07
7D
4.7%
1Y
22.2%
GNI Group
Market Cap: JP¥168.4b
Engages in the research, development, manufacturing, and sale of pharmaceuticals and biomaterials in Japan, China, and the United States.
2160
JP¥3,020.00
7D
-4.6%
1Y
25.1%
Diaceutics
Market Cap: UK£140.1m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.66
7D
-5.2%
1Y
36.2%